Global Blood Therapeutics stock declines after forsaking half its drug pipeline By: MarketWatch October 23, 2017 at 11:19 AM EDT After investing millions in research and development, the company said the drug didn’t work well enough to keep going. Read More >> Related Stocks: Global Blood Ther Standard & Poors 500